ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Telephone and Data Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TDS, TDSPrU, TDSPrV

NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telephone and Data Systems, Inc. (the “Company” or “TDS”) (NYSE: TDS, TDSPrU, TDSPrV) between May 6, 2022 and November 3, 2022, both dates inclusive (the “Class Period”), of the important July 3, 2023 lead plaintiff deadline.

SO WHAT: If you purchased TDS securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the TDS class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 3, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Company and its subsidiary, United States Cellular Corporation (“UScellular”), made false and/or misleading statements and/or failed to disclose that: (1) defendants had no reason to believe UScellular’s “free upgrade” promotional activity, which was tested and trialed during the second quarter of 2022, was effective at reducing the Company’s postpaid churn rate as they represented to investors, as opposed to merely adding new postpaid subscribers, when its churn rate was actually increasing or remaining constant over most quarters in the class period; (2) UScellular was not making progress with respect to its churn rate, as it represented to investors; (3) UScellular was not in fact balancing its promotional activity and its profitability; (4) due to extreme competition among postpaid carriers, UScellular did not have the flexibility to offset the costs from widespread, expensive promotions with price increases; and (5) as a result of the Companies’ decision for UScellular to continue engaging in heavy promotions to address its postpaid subscriber churn rate despite any lack of positive impact on churn rate, UScellular’s profitability substantially declined. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TDS class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn:, on Twitter: or on Facebook:

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]

GlobeNewswire Distribution ID 8838498

Tri Ri Asset Management announces launch of Flagship VC fund

NERW YORK, May 12, 2023 (GLOBE NEWSWIRE) — Tri Ri Asset Management (“TRAM”) today announced the launch of their flagship venture capital fund, the TRAM Venture Fund (“TRAM VF”), with a target size of USD 125 million. TRAM VF will be focused on the MENA region, with a particular emphasis in Pakistan. Tri Ri Asset Impact Fund, with a commitment of USD 50 million, serves as the fund’s anchor. TRAM VF is dedicated to serving the later-stage tech company growth needs in Pakistan and MENA. The new fund’s deployment will focus on investing in innovative early-stage and growth-stage tech companies and enabling them to emerge into market leaders in GCC, South Asia, and North Africa.

TRAM VF will meet the needs of local startups and help them to become regional and global competitors. The local tech industry has recently seen substantial expansion; yet, funding is falling behind the quick speed of change and technological adoption. This has drawn global technology businesses as well as international venture capitalists to the region. TRAM VF will further accelerate the growth of the VC ecosystem in order to meet the increasing demand for technology products and services.

Adeel Hussain, General Partner of TRAM VF stated: “Following the successful launch of our PE Impact fund last year, we are pleased to announce the launch of our Flagship VC Fund TRAM VF and its initial closure of $92 million. A particular thanks to our anchor investor, as well as the LP a Swiss family office, whose commitment demonstrates how ripe the region is for VC investments.”

Asad Ali, Co-CIO & Principal added: “We look forward to deploying our first flagship VC fund in a region with such complex growth. Scaling from our roots in Real Estate our capital deployment strategy has always been the core of our rapid growth. We will be able to use the same strategies to assist early stage startups within the region to leverage and grow their business. Our investment strategy is defined by a data-driven approach, specialized sourcing capabilities, and an uncompromising commitment to meaningful collaboration with entrepreneurs. We are more than just investors; we are also builders, utilising our team’s market experience to propel firms more precisely than generalist organisations. Supporting entrepreneurs is a privilege that we never take for granted.”

TRAM VF will utilize its differentiated market expertise and metrics-driven evaluation process, to invests across Fintech, healthcare, consumer, education, food security, real estate, fintech, B2B, Artificial Intelligence across the region.

About Tri Ri Asset Management:
Tri Ri Asset Management, is a concentrated, research-intensive, fundamental value investor in the public markets. Since 2019, Tri Ri has executed an aggressive but disciplined growth strategy, building a balanced portfolio of public market and real estate holdings.
As of March 2023, Tri Ri’s portfolio composed of USD 850 million in assets under management along with USD 1.2 billion in Co-investments and 7 renowned properties with over 1500 rooms.

Richard Haig

GlobeNewswire Distribution ID 8838768

Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston

Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the Company, will attend the PEGS Boston Summit from May 15-19. He will deliver a keynote presentation on “The State of the Science in Disease Modeling Across Diverse Indications” on May 15 at 11AM at the Hynes Convention Center and join in an interactive discussion on May 15 at 12:45PM.

In his presentation, Dr. Zhavoronkov will make the first announcement of peptide-based drug design strategies and Generative Biologics, a new engine that belongs to the company’s end-to-end AI-driven drug discovery platform Pharma.AI that leverages hundreds of millions of biological data points, machine learning algorithms, and generative biology models to build and design polypeptides from scratch.

A team of expert scientists are developing Pharma.AI at the Insilico Medicine Generative Artificial Intelligence and Quantum Computing Research and Development Center in Abu Dhabi, the region’s largest AI-powered biotechnology research center.

“We are at an exciting moment in the history of generative AI in drug discovery,” says Zhavoronkov. “Thanks to years of accumulated data and technological advances in generative AI, we can find targets and design new small molecules for hard-to-treat diseases with incredible speed and efficiency working in close partnership with pharmaceutical companies. We look forward to using generative AI to explore diverse drug development strategies.”

Insilico Medicine was one of the first companies to use generative adversarial autoencoders for de-novo drug discovery. In 2016, the Company introduced the earliest iternation of its generative biology tool for identifying novel targets with a publication in Nature Communications. Another publication followed in Oncotarget, demonstrating how Insilico could employ generative algorithms with reinforcement learning to design novel small molecules with predefined and optimized properties. By 2018, Insilico integrated generative biology and chemistry approaches into the commercially available Pharma.AI platform that accelerates the process of lead discovery from years to days, and is currently being utilized by 11 of 20 top pharmaceutical companies.

The Company has also utilized the platform to develop its own robust pipeline of assets, including two drugs – for idiopathic pulmonary fibrosis and COVID-19 – currently in clinical trials and many potentially best-in-class and first-in-class assets in preclinical stages of development available for licensing. In total, Insilico has 31 programs across 29 targets, including in fibrosis, oncology, immunology, and central nervous system disorders.

Zhavoronkov says PEGS, the world’s largest gathering of protein engineering and biotherapeutics experts, is the perfect setting for announcing the latest developments to Insilico’s platform. “We were instrumental in the early development of generative biology and generative chemistry, and now we’re advancing AI-designed drugs into clinical trials. It is truly a pivotal moment.”

About Insilico Medicine

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. In early 2023, the Company opened the Insilico Medicine Generative Artificial Intelligence and Quantum Computing Research and Development Centre in Abu Dhabi, the region’s largest AI-powered biotechnology research center. The R&D hub brings together global talent in artificial intelligence and software development to expand the capabilities of Insilico’s end-to-end AI-driven drug discovery platform, Pharma.AI, explore aging research and sustainable chemistry, and support the digital transformation of healthcare in the region.

For more information, visit


Brita Belli
Insilico Medicine
[email protected]

GlobeNewswire Distribution ID 8838633

Pakistan: Pro-Khan Violent Protesters to Face Terror Trials

Pakistan’s civilian and military leadership Saturday vowed to hunt down and bring to justice all those involved in acts of violence during this week’s protests sparked by the brief arrest of the country’s popular former Prime Minister Imran Khan.

“I have given law enforcement apparatus a target of 72 hours to arrest all those involved in facilitating, abetting and perpetrating the disgraceful incidents of arson, ransacking, sabotage and damaging public and private properties,” incumbent Prime Minister Shehbaz Sharif said in a statement.

“Bringing these people to justice is a test case for the government. Their cases will be tried by the anti-terrorism courts,” he noted.

Pakistan’s military chief, General Asim Munir, backed Sharif’s resolve in a separate statement Saturday.

“The armed forces will not tolerate any further attempt to violate the sanctity and security of its installations or vandalism and resolve to bring to justice all the planners, abetters, instigators, and executors of vandalism,” a military statement quoted Munir as saying.

The government announced the crackdown as police have already rounded up nearly 3,000 supporters of Khan’s opposition Pakistan Tehreek-e-Insaf, or PTI, for their alleged role in several days of nationwide protests.

Detention sparks protests

Lingering political tensions escalated Tuesday after Pakistani paramilitary forces dragged and arrested Khan in the capital, Islamabad, from outside a courtroom as he prepared to attend a hearing in a legal challenge against him.

The detention of the 70-year-old cricket star-turned-prime minister on corruption charges sparked protests across Pakistan, some of which turned violent.

The Supreme Court declared the arrest unlawful, however, and Thursday ordered Khan to be set free, effectively defusing the street agitation, which saw protesters allegedly torching vehicles and state property.

Protesters also stormed the main gate of the military’s general headquarters in Rawalpindi, while others broke into the residence of a regional army commander in the eastern city of Lahore. In the northwestern city of Peshawar, protesters set fire to the building which is the home of the state-run radio station.

The violence killed at least 10 people and wounded several hundred, including police officers. Khan alleged that ‘live fire’ by security forces had killed at least 40 protesters.

Court bars arrest of Khan

On Friday, a federal high court barred police from arresting Khan for two weeks, enabling him to leave Islamabad hours later for his home in his native Lahore. He has faced dozens of cases, ranging from corruption and treason to terrorism and murder, since a parliamentary vote of no-confidence removed him from office less than four years into his term.

Khan rejects all the allegations and has persistently accused the powerful military of being behind the legal challenges to get him disqualified to block his return to power and ban his PTI party, the country’s largest political force.

Military officials reject the charges, and Sharif’s government insists corruption cases against the deposed prime minister are “genuine” and alleges the judiciary is being soft on Khan.

“Nobody can eliminate a political party by force and put them in jail,” Khan said in a televised address Saturday. His speech was streamed live on social media, including YouTube, because the government has barred local television channels from airing Khan’s statements.

He rejected allegations that PTI supporters were responsible for acts of violence during the protests and accused pro-government “infiltrators” of the incidents of arson and riots. Khan demanded an impartial investigation into the events starting with his unlawful arrest.

After protests broke out Tuesday, the government blocked internet access to social media platforms such as Facebook, YouTube, and Twitter across Pakistan and restored them partially late Friday. But the services again were inaccessible Saturday.

Source: Voice of America

Hasan Ali Smashes Sensational Half-Century in County Cricket [Video]

Renowned pacer, Hasan Ali, continues to impress in the ongoing edition of English County Cricket, demonstrating his batting prowess by scoring a quick-fire half-century.

Hasan Ali, who represents Warwickshire, proved to be a valuable asset for his team by contributing in both the bowling and batting departments against Essex at Edgbaston.

After helping his club bowl out Essex for 126 runs on the first day of the match, the 28-year-old pacer came in to bat with his team struggling at 172-9 in their first innings.

The right-arm fast bowler joined Oliver Hannon-Dalby at the crease and added a crucial 70-run partnership for the last wicket before Oliver was caught behind.

A power-hitting masterclass from Hassan Ali

His aggressive approach and clean hitting resulted in the Pakistan-born cricketer scoring his sixth fifty in first-class cricket, reaching his half-century off just 33 balls.

Hasan Ali remained unbeaten on 53 from 37 balls, including four fours and four sixes, helping the side reach 242 before the last-wicket partnership finally came to an end.

A display of phenomenal performance did not end there as he also played a crucial role in the second innings by taking the wicket of Alastair Cook in the third session of the day.

Source: Pro Pakistani